Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Operating Income (2021 - 2025)

Historic Operating Income for Kezar Life Sciences (KZR) over the last 5 years, with Q2 2025 value amounting to -$14.6 million.

  • Kezar Life Sciences' Operating Income rose 3756.58% to -$14.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$75.7 million, marking a year-over-year increase of 2935.45%. This contributed to the annual value of -$90.6 million for FY2024, which is 1868.45% up from last year.
  • Kezar Life Sciences' Operating Income amounted to -$14.6 million in Q2 2025, which was up 3756.58% from -$17.6 million recorded in Q1 2025.
  • Over the past 5 years, Kezar Life Sciences' Operating Income peaked at -$13.0 million during Q2 2021, and registered a low of -$34.6 million during Q4 2023.
  • Moreover, its 5-year median value for Operating Income was -$20.0 million (2022), whereas its average is -$20.4 million.
  • Its Operating Income has fluctuated over the past 5 years, first plummeted by 7265.15% in 2023, then soared by 3765.94% in 2024.
  • Quarter analysis of 5 years shows Kezar Life Sciences' Operating Income stood at -$14.1 million in 2021, then tumbled by 42.05% to -$20.0 million in 2022, then plummeted by 72.65% to -$34.6 million in 2023, then soared by 37.66% to -$21.6 million in 2024, then skyrocketed by 32.3% to -$14.6 million in 2025.
  • Its Operating Income was -$14.6 million in Q2 2025, compared to -$17.6 million in Q1 2025 and -$21.6 million in Q4 2024.